Jason P Rhodes - Net Worth and Insider Trading
Jason P Rhodes Net Worth
The estimated net worth of Jason P Rhodes is at least $244 Million dollars as of 2024-04-23. Jason P Rhodes is the Director of Dyne Therapeutics Inc and owns about 8,050,704 shares of Dyne Therapeutics Inc (DYN) stock worth over $200 Million. Jason P Rhodes is the Director of Generation Bio Co and owns about 8,279,484 shares of Generation Bio Co (GBIO) stock worth over $23 Million. Jason P Rhodes is also the Director of Replimune Group Inc and owns about 3,228,912 shares of Replimune Group Inc (REPL) stock worth over $21 Million. Details can be seen in Jason P Rhodes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason P Rhodes has not made any transactions after 2024-02-28 and currently still holds the listed stock(s).
Transaction Summary of Jason P Rhodes
Jason P Rhodes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason P Rhodes owns 5 companies in total, including Dyne Therapeutics Inc (DYN) , Generation Bio Co (GBIO) , and Replimune Group Inc (REPL) among others .
Click here to see the complete history of Jason P Rhodes’s form 4 insider trades.
Insider Ownership Summary of Jason P Rhodes
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-02-28 | director & 10 percent owner |
GBIO | Generation Bio Co | 2021-09-29 | director |
REPL | Replimune Group Inc | 2021-01-26 | director |
EPZM | Epizyme Inc | 2013-05-30 | 10 percent owner & EVP & CFO and Treasurer |
IRON | Disc Medicine Inc | 2021-10-04 | director & 10 percent owner |
Jason P Rhodes Latest Holdings Summary
Jason P Rhodes currently owns a total of 3 stocks. Among these stocks, Jason P Rhodes owns 8,050,704 shares of Dyne Therapeutics Inc (DYN) as of February 28, 2024, with a value of $200 Million and a weighting of 82.01%. Jason P Rhodes owns 8,279,484 shares of Generation Bio Co (GBIO) as of September 29, 2021, with a value of $23 Million and a weighting of 9.5%. Jason P Rhodes also owns 3,228,912 shares of Replimune Group Inc (REPL) as of January 26, 2021, with a value of $21 Million and a weighting of 8.49%.
Latest Holdings of Jason P Rhodes
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-02-28 | 8,050,704 | 24.87 | 200,221,008 |
GBIO | Generation Bio Co | 2021-09-29 | 8,279,484 | 2.80 | 23,182,555 |
REPL | Replimune Group Inc | 2021-01-26 | 3,228,912 | 6.42 | 20,729,615 |
Holding Weightings of Jason P Rhodes
Jason P Rhodes Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason P Rhodes has made a total of 4 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 807,838 shares on February 28, 2024, which brought Jason P Rhodes around $20 Million.
According to the SEC Form 4 filings, Jason P Rhodes has made a total of 6 transactions in Generation Bio Co (GBIO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Generation Bio Co is the sale of 81,088 shares on September 29, 2021, which brought Jason P Rhodes around $2 Million.
According to the SEC Form 4 filings, Jason P Rhodes has made a total of 6 transactions in Replimune Group Inc (REPL) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Replimune Group Inc is the sale of 5,558 shares on January 26, 2021, which brought Jason P Rhodes around $256,446.
Insider Trading History of Jason P Rhodes
- 1
Jason P Rhodes Trading Performance
GuruFocus tracks the stock performance after each of Jason P Rhodes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason P Rhodes is 26.97%. GuruFocus also compares Jason P Rhodes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason P Rhodes within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason P Rhodes's insider trading performs compared to the benchmark.
Performance of Jason P Rhodes
Average Return
150.24%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 11.76 | 26.97 | 42.67 | 150.24 | 67.33 | 16.83 |
Relative Return to S&P 500(%) | 10.75 | 24.61 | 41 | 134.94 | 44.61 | 8.54 |
Jason P Rhodes Ownership Network
Ownership Network List of Jason P Rhodes
Ownership Network Relation of Jason P Rhodes
Jason P Rhodes Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Jason P Rhodes is the director & 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include Chief Medical Officer Wildon Farwell , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Jason P Rhodes made 4 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 884,198. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 241,325 shares made by Jonathan Mcneill , a net sale of 191,946 shares made by Richard William Scalzo , and a net sale of 1,171,794 shares made by Joshua T Brumm .
In summary, during the past 3 months, insiders sold 4,554,480 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 4,554,480 shares. During the past 18 months, 5,472,903 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,889,456 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Jason P Rhodes Mailing Address
Above is the net worth, insider trading, and ownership report for Jason P Rhodes. You might contact Jason P Rhodes via mailing address: C/o Epizyme, Inc., 400 Technology Square, 4th Floor, Cambridge Ma 02139.